Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4021f8d8a53258a5a3615b4139dd1eee |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate |
2004-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2009-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abf4e08df7300fb394d6dba85c6a2d15 |
publicationDate |
2009-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2330115-T3 |
titleOfInvention |
ANTIBACTERIAL COMPOSITION, MORE PARTICILARALLY AGAINST GRAM-NEGATIVE BACTERIA, WHICH INCLUDES A PEPTIDE AND AN ANTIBACTERIAL AGENT ADVANTAGES HYDROPHOBO ADVANTAGES. |
abstract |
The use of at least one peptide of 10 to 25 amino acid residues covalently linked to an antibacterial compound, said peptide or peptides comprising: i) two positively charged domains at neutral pH each consisting of 3 to 9 amino acid residues, of which which at least two thirds are cationic amino acids, ii) between said positively charged domains, a group of two to three non-cationic amino acid residues, iii) at one and / or another of the N or C terminal ends of the peptide, a group of 0 to 10 amino acid residues chosen from the group comprising non-hydrophobic amino acids and positively charged amino acids, but in the case of a positively charged amino acid residue it is not directly adjacent to positively charged domains. for the preparation of a pharmaceutical composition intended for the treatment of an infection caused by Gram-negative bacteria. |
priorityDate |
2003-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |